Stelios Papadopoulos, Director at BG Medicine, Inc. (BGMD), bought 250,000 shares at $2.00 ($500K) on 2013-01-30, disclosed to the SEC on 2013-02-01.
Open-market purchase of $500k BGMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| EXEL | SELL | 2024-05-22 | $240K | — | Filing → |
| EXEL | SELL | 2022-02-24 | $3.3M | — | Filing → |
| EXEL | SELL | 2021-05-13 | $911K | — | Filing → |